AbbVie's Q1 earnings beat estimates, with a smaller decline in Humira sales than expected.The company's next-generation drugs, Rinvoq and Skyrizi, are offsetting the decline in Humira sales.AbbVie's ...
Source LinkAbbVie's Q1 earnings beat estimates, with a smaller decline in Humira sales than expected.The company's next-generation drugs, Rinvoq and Skyrizi, are offsetting the decline in Humira sales.AbbVie's ...
Source Link
Comments